Q14 Analytical Procedure Development
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 7, 2024
March 7, 2024
7f445a67-e90c-4c67-a0c6-958d21e1d405
Related Documents
M12 Drug Interaction Studies
Guidance DocumentAugust 2, 2024Center for Drug Evaluation and Research
Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Q2(R2) Validation of Analytical Procedures
Guidance DocumentMarch 6, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.